Literature DB >> 34230524

Prediction of non-responsiveness to pre-dialysis care program in patients with chronic kidney disease: a retrospective cohort analysis.

Emily K King1,2, Ming-Han Hsieh3, David R Chang3, Cheng-Ting Lu3, I-Wen Ting3,2, Charles C N Wang4,5, Pei-Shan Chen2, Hung-Chieh Yeh3,2,6, Hsiu-Yin Chiang2, Chin-Chi Kuo7,8,9.   

Abstract

The responsiveness of patients with chronic kidney disease (CKD) to nephrologists' care is unpredictable. We defined the longitudinal stages (LSs) 1-5 of estimated glomerular filtration rate (eGFR) by group-based trajectory modeling for repeated eGFR measurements of 7135 patients with CKD aged 20-90 years from a 13-year pre-end-stage renal disease (ESRD) care registry. Patients were considered nonresponsive to the pre-dialysis care if they had a more advanced eGFR LS compared with the baseline. Conversely, those with improved or stable eGFR LS were considered responsive. The proportion of patients with CKD stage progression increased with the increase in the baseline CKD stage (stages 1-2: 29.2%; stage 4: 45.8%). The adjusted times to ESRD and all-cause mortality in patients with eGFR LS-5 were 92% (95% confidence interval [CI] 86-96%) and 57% (95% CI 48-65%) shorter, respectively, than in patients with eGFR LS-3A. Among patients with baseline CKD stages 3 and 4, the adjusted times to ESRD and all-cause death in the nonresponsive patients were 39% (95% CI 33-44%) and 20% (95% CI 14-26%) shorter, respectively, than in the responsive patients. Our proposed Renal Care Responsiveness Prediction (RCRP) model performed significantly better than the conventional Kidney Failure Risk Equation in discrimination, calibration, and net benefit according to decision curve analysis. Non-responsiveness to nephrologists' care is associated with rapid progression to ESRD and all-cause mortality. The RCRP model improves early identification of responsiveness based on variables collected during enrollment in a pre-ESRD program. Urgent attention should be given to characterize the underlying heterogeneous responsiveness to pre-dialysis care.

Entities:  

Year:  2021        PMID: 34230524     DOI: 10.1038/s41598-021-93254-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  23 in total

1.  Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States.

Authors:  Austin G Stack
Journal:  Am J Kidney Dis       Date:  2003-02       Impact factor: 8.860

2.  Multi-Trajectory Models of Chronic Kidney Disease Progression.

Authors:  Philipp Burckhardt; Daniel S Nagin; Rema Padman
Journal:  AMIA Annu Symp Proc       Date:  2017-02-10

3.  Multidisciplinary care program for advanced chronic kidney disease: reduces renal replacement and medical costs.

Authors:  Ping Min Chen; Tai Shuan Lai; Ping Yu Chen; Chun Fu Lai; Shao Yu Yang; VinCent Wu; Chih Kang Chiang; Tze Wah Kao; Jenq Wen Huang; Wen Chih Chiang; Shuei Liong Lin; Kuan Yu Hung; Yung Ming Chen; Tzong Shinn Chu; Ming Shiou Wu; Kwan Dun Wu; Tun Jun Tsai
Journal:  Am J Med       Date:  2014-08-19       Impact factor: 4.965

Review 4.  Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes.

Authors:  Andrzej S Krolewski; Jan Skupien; Peter Rossing; James H Warram
Journal:  Kidney Int       Date:  2017-03-31       Impact factor: 10.612

5.  Predialysis nephrology care of older patients approaching end-stage renal disease.

Authors:  Wolfgang C Winkelmayer; Jun Liu; Glenn M Chertow; Manjula Kurella Tamura
Journal:  Arch Intern Med       Date:  2011-08-08

6.  Dialysis Initiation and Mortality Among Older Veterans With Kidney Failure Treated in Medicare vs the Department of Veterans Affairs.

Authors:  Manjula Kurella Tamura; I-Chun Thomas; Maria E Montez-Rath; Kristopher Kapphahn; Manisha Desai; Randall C Gale; Steven M Asch
Journal:  JAMA Intern Med       Date:  2018-05-01       Impact factor: 21.873

7.  Progression of stages 3b-5 chronic kidney disease--preliminary results of Taiwan national pre-ESRD disease management program in Southern Taiwan.

Authors:  Chun-Mei Lin; Ming-Chin Yang; Shang-Jyh Hwang; Junne-Ming Sung
Journal:  J Formos Med Assoc       Date:  2013-12-03       Impact factor: 3.282

8.  Economic evaluation of a pre-ESRD pay-for-performance programme in advanced chronic kidney disease patients.

Authors:  Hui-Min Hsieh; Ming-Yen Lin; Yi-Wen Chiu; Ping-Hsun Wu; Li-Jeng Cheng; Feng-Shiuan Jian; Chih-Cheng Hsu; Shang-Jyh Hwang
Journal:  Nephrol Dial Transplant       Date:  2017-07-01       Impact factor: 5.992

9.  Renal Function Trajectories in Patients with Prior Improved eGFR Slopes and Risk of Death.

Authors:  Yan Xie; Benjamin Bowe; Hong Xian; Sumitra Balasubramanian; Ziyad Al-Aly
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

10.  Effect of national pre-ESRD care program on expenditures and mortality in incident dialysis patients: A population-based study.

Authors:  Ming-Yen Lin; Li-Jen Cheng; Yi-Wen Chiu; Hui-Min Hsieh; Ping-Hsun Wu; Yi-Ting Lin; Shu-Li Wang; Feng-Xuan Jian; Chih Cheng Hsu; Shu-An Yang; Huei-Lan Lee; Shang-Jyh Hwang
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

View more
  1 in total

1.  Association of poorly controlled HbA1c with increased risk of progression to end-stage kidney disease and all-cause mortality in patients with diabetes and chronic kidney disease.

Authors:  Sheng-Jen Chen; Hsiu-Yin Chiang; Pei-Shan Chen; Shih-Ni Chang; Sheng-Hsuan Chen; Min-Yen Wu; Hung-Chieh Yeh; I-Wen Ting; Hsiu-Chen Tsai; Pei-Chun Chen; Chin-Chi Kuo
Journal:  PLoS One       Date:  2022-09-26       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.